Please wait while the formulary information is being retrieved.
PNEUMOVAX 23 (PNEUMOCOCCAL 23-VAL P-SAC VAC)
- Prevention of streptococcus pneumoniae infection
25 mcg/0.5 mL injection syringe
- Inject 0.5 milliliter by intramuscular route once
25 mcg/0.5 mL injection solution
- Inject 0.5 milliliter by intramuscular route once
25 mcg/0.5 mL injection solution
- Inject 0.5 milliliter by intramuscular route once
Prevention of streptococcus pneumoniae infection
- Inject 0.5 milliliter by intramuscular route once
- Inject 0.5 milliliter by subcutaneous route once
- None
Contraindicated
- fingolimod
- Gilenya
Severe
Moderate
- varicella virus vacc live (PF)
- Varivax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
- None
Contraindicated
- High fever >101 degrees fahrenheit
Severe
Moderate
- None
PNEUMOVAX 23 (PNEUMOCOCCAL 23-VAL P-SAC VAC)
- Prevention of streptococcus pneumoniae infection
- None
- Erythema
- Induration of skin
- Injection site sequelae
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Angioedema
- Febrile convulsions
- Guillain-barre syndrome
- High fever >101 degrees fahrenheit
- Serum sickness
- Urticaria
Less Severe
- Arthralgias
- Arthritis
- Chills
- Fever
- General weakness
- Headache disorder
- Leukocytosis
- Lymphadenopathy
- Malaise
- Myalgias
- Nausea
- Pain
- Paresthesia
- Peripheral edema
- Skin rash
- Vomiting
Contraindicated
None
Severe Precaution
Pneumococcal 23-Val Polysac Vac
Not approved and not recommended for children age < 2 years.
- 1 Day – 2 Years
- Not approved and not recommended for children age < 2 years.
Management or Monitoring Precaution
None
Pneumococl 23-val Polysac Vac
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Pneumococcal 23-val Polysac Vac
Caution should be exercised.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Caution should be exercised. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Prevention of streptococcus pneumoniae infection | |
| Z23 | Encounter for immunization |
| 0-9 | A-Z |
|---|---|
| Z23 | Encounter for immunization |
Formulary Reference Tool